Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study

Journal:

Journal of the American Academy of Dermatology

Published:

2026-02-12

DOI:

10.1016/j.jaad.2026.02.025

Affiliations:

30

Authors:

31

Go to article

Institutions	Authors	Share
Blueprint Medicines, United States of America (USA)	5.000000	0.16
ARUP Laboratories, Utah, United States of America (USA)	2.000000	0.06
Health Sciences Center (HSC), Utah, United States of America (USA)	2.000000	0.06
Odense University Hospital (OUH), Denmark	1.000000	0.03
Brigham and Women's Hospital (BWH), United States of America (USA)	1.000000	0.03
Hôpital Larrey, CHU-Toulouse, France	1.000000	0.03
AP-HP Pitié-Salpêtrière Hospital, France	1.000000	0.03
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany	1.000000	0.03
Oslo University Hospital (OUS), Norway	1.000000	0.03
University of Michigan (U-M), United States of America (USA)	1.000000	0.03
Erasmus University Medical Center (Erasmus MC), Netherlands	1.000000	0.03
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)	1.000000	0.03
University of Calgary (U of C), Canada	1.000000	0.03
Rush University Medical Center, United States of America (USA)	1.000000	0.03
Antwerp University Hospital (UZA), UA, Belgium	1.000000	0.03
Stanford University School of Medicine, United States of America (USA)	1.000000	0.03
Beatson West of Scotland Cancer Centre (BWoSCC), United Kingdom (UK)	1.000000	0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.03
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany	1.000000	0.03
Karolinska Institute (KI), Sweden	1.000000	0.03
Rainbow Babies & Children's Hospital, United States of America (USA)	1.000000	0.03
University Hospital Basel (USB), UB, Switzerland	1.000000	0.03
Charité - University Medicine Berlin, Germany	0.500000	0.02
Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Germany	0.500000	0.02
Hospital Virgen del Valle, Spain	0.500000	0.02
Institute for the Study of Mastocytosis of Castilla La Mancha (CLMast), Spain	0.500000	0.02
University Hospital Aachen (UKA), RWTH Aachen, Germany	0.500000	0.02
Center for Integrated Oncology Aachen Bonn Köln Düsseldorf (CIO), Germany	0.500000	0.02